C A SE S PE R Y E A RC A N C E R

Access to high quality care

Receive newer, potentially better treatments

Benefit future patients

a clinical trial tests newly developed medicines and procedures to improve patient outcomes

Between 2006-2013, icorG has enabled over

5,632 patients access to research treatments

patients participated in icorG led clinical trials in 2013

14clinical trial centres in ireland

1600

to enable irish patients to gain early access to new cancer treatments

TOP 3 BENEFITS

WhAT IS A ClINICAl TRIAl?

DRUGS

www.icorg.ie/clinical-trials

WhAT ARE WE DOING?

received excellent or good quality care

Based on a US-survey of nearly 6000 cancer patients

had an overall positive experience

were treated with dignity & respect

97%

93%97%

SourceS: 1. comis r, Aldige c, Stovall e, Krebs L, risher P, Taylor H. A

quantitative survey of public attitudes towards cancer clinical Trials. Proc Am Soc clin oncol. 19:2000

2. IcorG Database 3. Irish Medicines Board

Annual reports

Graphics created by:

INvESTmENT

ThAT ThE NUmBER OF PEOPlE AFFECTED BY

CANCER IS INCREASING

1,101Clinical Trials were approved by the IMB in Ireland between 2003-2012

new cancer drugs made available in Ireland in the last 10 years

32

20,000 30,000

If you have any queries on participating in a Clinical Trial, or on Clinical Trials in general, please speak with your oncologist.

in ireland, 9 major pharmaceutical companies have:

An estimated current investment of

in Clinical Trials€32mExpect to increase this to

by 2020€100m